Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What's new in stroke?

R G Hart1, J J Rohack, D H Solomon

  • 1University of Texas Health Science Center, San Antonio, USA.

Texas Medicine
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Duration and dose of allopurinol needed to attain the serum urate target in gout.

Scandinavian journal of rheumatology·2026
Same author

No association between vascular inflammation and estimated glomerular filtration rate in patients with rheumatoid arthritis: secondary analysis of the TARGET trial.

Scandinavian journal of rheumatology·2025
Same author

Associations among temporal and large artery abnormalities on vascular ultrasound in giant cell arteritis.

Scandinavian journal of rheumatology·2021
Same author

Healing of erosions in rheumatoid arthritis remains elusive: results with 24 months of the anabolic agent teriparatide.

Scandinavian journal of rheumatology·2020
Same author

Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial.

European journal of neurology·2020
Same author

Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees.

Osteoarthritis and cartilage·2019
Same journal

Commentary: This Is Not a Drill.

Texas medicine·2021
Same journal

Healthy Determination: Texas Physicians are Finding Better Ways to Address Their Patients' Social Determinants of Health.

Texas medicine·2021
Same journal

Going Local: Accountable Health Organizations Could Help Combat Social Disparities at the Local Level.

Texas medicine·2021
Same journal

Data Driven: Medicaid's Inspector General Focuses on Fraud Prevention, Not Just Prosecution.

Texas medicine·2021
Same journal

Talk to Patients About: Vaccine Adverse Event Reporting System (VAERS).

Texas medicine·2021
Same journal

Obstacles to Clear.

Texas medicine·2021
See all related articles

Most strokes are preventable with existing therapies. Optimal application of risk-factor management, antiplatelet drugs, and anticoagulation for atrial fibrillation can significantly reduce stroke incidence.

Area of Science:

  • Neurology
  • Preventive Medicine
  • Cardiovascular Research

Background:

  • Over 30,000 strokes occur annually in Texas, highlighting a significant public health concern.
  • Despite the high incidence, a majority of strokes are preventable through established therapeutic interventions.

Purpose of the Study:

  • To review current evidence on stroke prevention strategies.
  • To emphasize the importance of risk-factor management alongside antithrombotic and surgical therapies.

Main Methods:

  • Review of existing literature on antiplatelet therapy, anticoagulation, and surgical interventions for stroke prevention.
  • Analysis of the role of risk-factor modification, including hypertension control, smoking cessation, and hyperlipidemia treatment.

Related Experiment Videos

Main Results:

  • Antiplatelet therapy (aspirin, ticlopidine) reduces stroke risk by approximately 25% in patients with transient ischemic attack or initial stroke.
  • Warfarin is indicated for preventing cardioembolic stroke, particularly in patients with nonvalvular atrial fibrillation.
  • Carotid endarterectomy benefits patients with high-grade symptomatic carotid stenosis; its efficacy in other scenarios is less defined.
  • Comprehensive risk-factor management is as crucial as specific antithrombotic or surgical treatments for preventing threatened strokes.

Conclusions:

  • Most strokes are preventable, underscoring the need for optimal implementation of available preventive measures.
  • Integrated management combining pharmacotherapy, surgical options, and aggressive risk-factor control is essential for maximizing stroke prevention.
  • Tailoring preventive strategies based on the determined cause of threatened stroke is critical for effective patient outcomes.